<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595721</url>
  </required_header>
  <id_info>
    <org_study_id>HM20020881</org_study_id>
    <nct_id>NCT04595721</nct_id>
  </id_info>
  <brief_title>Comparison of Physical Versus Visual Distraction in the Reduction of Pain During Local Anesthesia</brief_title>
  <official_title>Comparison of Physical Versus Visual Distraction in the Reduction of Pain During Local Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare physical versus visual distractions to determine&#xD;
      which technique reduces perceived pain better during local anesthesia injections.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before the local anesthesia injection, patients will be asked to give a preliminary VAS score&#xD;
      based on what level of pain 0-10 they anticipate they will feel during the local anesthesia&#xD;
      injection. Following the injection the participant will be asked to quantify the pain felt&#xD;
      during the injection on a 0-10 Visual analog scale (VAS). The VAS scores will only be taken&#xD;
      from the first injection of the appointment. Participants will be asked their gender, race,&#xD;
      age, geographic location they spent most of their lives as well. Participants will be&#xD;
      de-identified and randomly assigned a number that will be recorded along with their collected&#xD;
      data on a two-factor, password protected web server. Information collected during this study&#xD;
      may be used for further analysis and publication.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain</measure>
    <time_frame>Up to 30 minutes</time_frame>
    <description>Participants will be asked to rate their pain on a visual analog pain scale. The scale is rated from 0 (no pain) to 10 (pain as bad as it can be)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">149</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive standard injection procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Visual distraction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants engage in visual distraction during the injection procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical distraction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants engage in physical distraction during the injection procedures</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hidden object</intervention_name>
    <description>Participant will be instructed to look at the hidden object image on the overhead light to look for a number of objects and observe the image.</description>
    <arm_group_label>Visual distraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress ball</intervention_name>
    <description>Participants will be handed a single-use, squeezable stress ball and instructed to squeeze the stress ball.</description>
    <arm_group_label>Physical distraction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients needing a dental procedure that requires a buccal infiltration with&#xD;
             Septocaine 1:100,000 epinephrine (EPI) (Articaine hydrochloride 4% and EPI 1:100,000)&#xD;
             or an inferior alveolar nerve block injection with 2% lidocaine with 1:100,000&#xD;
             epinephrine.&#xD;
&#xD;
          -  Adults greater than 18 years old.&#xD;
&#xD;
          -  Patients with limited English proficiency will be included only if their primary&#xD;
             language is Spanish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a known or suspected allergy to anesthetic agent, sulfites, amide-type&#xD;
             local anesthetic, or to any ingredient in anesthetic solutions will not be included.&#xD;
&#xD;
          -  Any patients taking medications affecting pain response on the day of the dental&#xD;
             appointment.&#xD;
&#xD;
          -  Children younger than 18 years old.&#xD;
&#xD;
          -  Patients with limited English proficiency with a primary language other than Spanish&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis Formica, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caclinh Le</last_name>
    <phone>804 396 2965</phone>
    <email>lect@vcu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joshua Cardinal</last_name>
    <phone>385-777-6706</phone>
    <email>cardinaljr@vcu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dental pain</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

